Join
Live feed
·
INSIDERFilingvia Quantisnow
Traws Pharma Inc. logo

Director Leaman John Harold was granted 4,058 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TRAW· Traws Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRAW (Traws Pharma Inc.) and more on Quantisnow.